scholarly journals Evaluation of radial Extracorporeal Shock Wave Therapy (rESWT) as a treatment option in chronic post-stroke upper limb management

2021 ◽  
Vol 11 (5) ◽  
pp. 294-297
Author(s):  
Senarath MKID
Keyword(s):  
Shock Wave ◽  
Treatment Option ◽  
Upper Limb ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Post Stroke ◽  
Extracorporeal Shock Wave

scholarly journals Effects of Radial Extracorporeal Shock Wave Therapy on Flexor Spasticity of the Upper Limb in Post-stroke Patients: Study Protocol for A Randomized Controlled Trial

2020 ◽  
Author(s):  
Tao Fan ◽  
Xiangying Zhou ◽  
Peichen He ◽  
Xiaojia Zhan ◽  
Peng Zheng ◽  
...  
Keyword(s):  
Shock Wave ◽  
Upper Limb ◽  
Controlled Trial ◽  
Extracorporeal Shock Wave Therapy ◽  
Function Evaluation ◽  
Attractive Alternative ◽  
Shock Wave Therapy ◽  
Stroke Patients ◽  
Post Stroke ◽  
Extracorporeal Shock Wave

Abstract Background: Flexor Spasticity of the Upper Limb is common in post-stroke patients and seriously affects the recovery of upper limb function. However, there are no standard management protocols for this condition. Radial extracorporeal shock wave therapy (rESWT) is widely used as a non-invasive treatment method for various diseases, but its efficacy in reducing spasticity remains undefined. Methods/design: A prospective, randomized, double-blind controlled trial is to be performed to study the efficacy of rESWT on the treatment of upper limb spasticity after strokes. One hundred participants will be recruited from the Inpatient department of Zhujiang hospital for this study. Patients who meet the inclusion criteria will be randomly allocated to either receive 3 sessions of active rESWT (Group A) or sham-placebo rESWT (Group B) with three day intervals between each session. Assessment will be performed at baseline and at each of the post-rESWT time points (t1, t2 and t3). The primary assessment outcome will be the Modified Ashworth Scale, while the secondary assessment outcomes will include surface electromyography, MyotonPRO digital muscle function evaluation and infrared thermal imaging. Discussion: This trial is aimed at analyzing the application of rESWT for the management of spasticity after stroke via comprehensive and quantitative assessments. We hypothesized that after receiving active rESWT, patients will show greater improvement of upper limb muscles, compared with patients of the sham-placeborESWT group. The rESWT would be an attractive alternative to traditional methods and the results of this study may provide guidance and support for the further study of potential mechanisms.

Extracorporeal Shock Wave Therapy reduces upper limb spasticity and improves motricity in patients with chronic hemiplegia: A case series

2013 ◽  
Vol 33 (3) ◽  
pp. 399-405 ◽  
Author(s):  
Franco Troncati ◽  
Matteo Paci ◽  
Tefta Myftari ◽  
Bruna Lombardi
Keyword(s):  
Shock Wave ◽  
Upper Limb ◽  
Case Series ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Limb Spasticity

scholarly journals Effects of Extracorporeal Shock Wave Therapy on Muscle Spasticity in Post-Stroke Patients: An Ultrasonography and Clinical-Base Study

2016 ◽  
Vol 6 (3) ◽  
pp. 169-179 ◽  
Author(s):  
Maryam Rastgoo ◽  
Hadi Sarafraz ◽  
Hamidreza Najari ◽  
Mohammad Reza Hadian ◽  
Bijan Forough ◽  
...  
Keyword(s):  
Shock Wave ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Stroke Patients ◽  
Muscle Spasticity ◽  
Post Stroke ◽  
Extracorporeal Shock Wave ◽  
Base Study

scholarly journals Extracorporeal shock wave as adjuvant therapy for wrist and hand spasticity in post-stroke patients: a randomized controlled trial

2021 ◽  
Vol 48 (1) ◽  
Author(s):  
Samar Abd Alhamed Tabra ◽  
Mohammad Ibrahim Zaghloul ◽  
Doaa Shawky Alashkar
Keyword(s):  
Shock Wave ◽  
Upper Limb ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Stroke Patients ◽  
Extracorporeal Shock Wave ◽  
Group I ◽  
Limb Spasticity ◽  
Group Ii

Abstract Background Stroke patients often present with upper limb spasticity which impairs the functional status of patients. Recently, extracorporeal shock wave therapy (ESWT) is reported to be a safe, non-invasive, alternative treatment for spasticity. Many articles have been published on the effect of ESWT on lower limb spasticity, but only few of them had focused on upper limb spasticity, so the aim of this study is to evaluate the clinical and electrophysiological effect of ESWT on wrist and hand spasticity of chronic stroke patients and its impact on functional performance. In this monocentric study, forty chronic stroke patients with upper limb spasticity were recruited and randomly allocated into two groups. Both groups continued to receive conventional stroke rehabilitative program, while group I received three sessions of radial extracorporeal shock wave therapy (rESWT) 1 week apart. Results There was a significant decrease in wrist and hand spasticity after treatment and at follow-up in group I compared to group II (Modified Ashworth Scale after rESWT 1.45 ± 0.16, 2.90 ± 0.18 and follow-up 1.55 ± 0.13, 3.00 ± .0.15 in groups I and II, respectively). Also, there was a significant improvement of wrist control and hand function after treatment and at follow-up in group I compared to group II (p < 0.001). The improvement of pinch grip was noticed at follow-up with a significant difference relative to baseline in group I (p < 0.05). Hmax/Mmax ratio was significantly decreased at follow-up in group I compared to group II (p < 0.001). Conclusion ESWT is a valuable adjuvant treatment for spasticity of the hand and wrist in stroke patients which is reflected as improvement of functional activity. Trial registration ClinicalTrials.gov, NCT04312581. Registered on 18 March 2020.

The effectiveness of extracorporeal shock wave therapy for improving upper limb spasticity and functionality in stroke patients: a systematic review and meta-analysis

2020 ◽  
Vol 34 (9) ◽  
pp. 1141-1156 ◽  
Author(s):  
Rosa Cabanas-Valdés ◽  
Pol Serra-Llobet ◽  
Pere Ramón Rodriguez-Rubio ◽  
Carlos López-de–Celis ◽  
Mercé Llauró-Fores ◽  
...  
Keyword(s):  
Shock Wave ◽  
Upper Limb ◽  
Meta Analysis ◽  
Extracorporeal Shock Wave Therapy ◽  
Controlled Trials ◽  
Shock Wave Therapy ◽  
Randomized Controlled ◽  
Extracorporeal Shock Wave ◽  
Limb Spasticity ◽  
Conventional Physiotherapy

Objective: To assess the effectiveness of Extracorporeal Shock Wave Therapy for reducing spasticity and improving functionality of the upper limb in stroke survivors. Data sources: A systematic review of MEDLINE, Cochrane Central Register of Controlled Trials, CINAHL, PEDro, REHABDATA, Scielo, Scopus, Web of Science, Tripdatabase and Epistemonikos from 1980 to April 2020 was carried out. Review methods: The bibliography was screened to identify randomized controlled clinical trials that applied extracorporeal shock waves to upper limb spastic muscles in post-stroke individuals. Two reviewers independently screened references, selected relevant studies, extracted data and assessed risk of bias using the PEDro scale. The primary outcome was spasticity and functionality of the upper limb. Results: A total of 1,103 studies were identified and 16 randomized controlled trials were finally included (764 individuals) were analyzed. A meta-analysis was performed and a beneficial effect on spasticity was found. The mean difference (MD) on the Modified Ashworth Scale for comparison extracorporeal shock wave versus sham was −0.28; with a 95% confidence interval (CI) from −0.54 to −0.03. The MD of the comparison of extracorporeal shock wave plus conventional physiotherapy versus conventional physiotherapy was −1.78; 95% CI from −2.02 to −1.53. The MD for upper limb motor-function using the Fugl Meyer Assessment was 0.94; 95% CI from 0.42 to 1.47 in the short term and 0.97; 95% CI from 0.19 to 1.74 in the medium term. Conclusion: The extracorporeal shock wave therapy is effective for reducing upper limb spasticity. Adding it to conventional therapy provides an additional benefit.

scholarly journals Clinical and Radiological Outcomes of Extracorporeal Shock Wave Therapy in Early-Stage Femoral Head Osteonecrosis

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Abdulrahman D. Algarni ◽  
Hassan M. Al Moallem
Keyword(s):  
Shock Wave ◽  
Femoral Head ◽  
Clinical Outcomes ◽  
Treatment Option ◽  
Early Stage ◽  
Extracorporeal Shock Wave Therapy ◽  
Harris Hip Score ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Femoral Head Osteonecrosis

Objective. Femoral head osteonecrosis is a progressive clinical condition with significant morbidity and long-term disability. Several treatment modalities including both surgical and nonsurgical options have been used with variable levels of success. High-energy extracorporeal shock wave therapy is a nonoperative treatment option that has been described for early-stage disease. We aimed to assess the functional and radiological outcomes of extracorporeal shockwave therapy (ESWT) in the treatment of osteonecrosis of the femoral head (ONFH). Methods. Thirty-three hips of 21 patients were included in this study. Adult patients with ONFH of any etiology and in the precollapse stage were included. Clinical (visual analogue scale [VAS] and Harris hip score [HHS]) and radiological (plain radiographs and magnetic resonance imaging [MRI]) evaluations were performed before and after intervention. We used 3000–4500 pulses in a single session performed under general anesthesia. Results. At an average of 8 months after ESWT, pain scores and HHS were significantly improved compared with the preintervention scores (p<0.001). The overall clinical outcomes were improved in 21 hips (63.3%), unchanged in 5 hips (15.15%), and worsened in 7 hips (21.2%). A trend toward a decrease in the size of the ONFH was observed although not of clinical significance (p=0.235). MRI revealed significant resolution of bone marrow edema (p<0.003). Regression was observed in 9 lesions (42.9%) and progression in 1 lesion (4.7%); no change was observed in the remaining 23 lesions (52.4%). Conclusion. ESWT is a viable noninvasive treatment option for early-stage ONFH. It significantly improves clinical outcomes and may halt or delay the radiographic progression of the disease in the precollapse stage.

scholarly journals Feasibility of Extracorporeal Shock Wave Therapy for Complex Upper Limb Morbidity in Breast Cancer Patient

Clinical Pain ◽  
2021 ◽  
Vol 20 (1) ◽  
pp. 25-29
Author(s):  
Min Cheol Ha ◽  
Ji Cheol Shin ◽  
Yu Sang Jung ◽  
Sang Hee Im
Keyword(s):  
Breast Cancer ◽  
Shock Wave ◽  
Cancer Patient ◽  
Breast Cancer Patient ◽  
Upper Limb ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave
Sign in / Sign up

Export Citation Format

Share Document